Tandem Diabetes Care Statistics
Total Valuation
FRA:TD5A has a market cap or net worth of EUR 1.20 billion. The enterprise value is 1.31 billion.
| Market Cap | 1.20B |
| Enterprise Value | 1.31B |
Important Dates
The next estimated earnings date is Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 67.80M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.23% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 104.84% |
| Float | 62.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| PB Ratio | 10.56 |
| P/TBV Ratio | 10.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.57 |
| EV / Sales | 1.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -61.29 |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 3.42.
| Current Ratio | 2.44 |
| Quick Ratio | 1.76 |
| Debt / Equity | 3.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -18.08 |
| Interest Coverage | -11.31 |
Financial Efficiency
Return on equity (ROE) is -109.73% and return on invested capital (ROIC) is -8.36%.
| Return on Equity (ROE) | -109.73% |
| Return on Assets (ROA) | -5.93% |
| Return on Invested Capital (ROIC) | -8.36% |
| Return on Capital Employed (ROCE) | -13.98% |
| Revenue Per Employee | 323,874 |
| Profits Per Employee | -65,407 |
| Employee Count | 2,650 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 3.25 |
Taxes
| Income Tax | -1.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.75% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -34.75% |
| 50-Day Moving Average | 13.39 |
| 200-Day Moving Average | 15.26 |
| Relative Strength Index (RSI) | 66.68 |
| Average Volume (20 Days) | 70 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.17 |
Income Statement
In the last 12 months, FRA:TD5A had revenue of EUR 858.27 million and -173.33 million in losses. Loss per share was -2.60.
| Revenue | 858.27M |
| Gross Profit | 456.84M |
| Operating Income | -74.15M |
| Pretax Income | -174.67M |
| Net Income | -173.33M |
| EBITDA | -59.30M |
| EBIT | -74.15M |
| Loss Per Share | -2.60 |
Balance Sheet
The company has 271.98 million in cash and 387.10 million in debt, giving a net cash position of -115.12 million.
| Cash & Cash Equivalents | 271.98M |
| Total Debt | 387.10M |
| Net Cash | -115.12M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 113.33M |
| Book Value Per Share | 1.67 |
| Working Capital | 310.58M |
Cash Flow
In the last 12 months, operating cash flow was -7.49 million and capital expenditures -13.92 million, giving a free cash flow of -21.41 million.
| Operating Cash Flow | -7.49M |
| Capital Expenditures | -13.92M |
| Free Cash Flow | -21.41M |
| FCF Per Share | n/a |
Margins
Gross margin is 53.23%, with operating and profit margins of -8.64% and -20.20%.
| Gross Margin | 53.23% |
| Operating Margin | -8.64% |
| Pretax Margin | -20.35% |
| Profit Margin | -20.20% |
| EBITDA Margin | -6.91% |
| EBIT Margin | -8.64% |
| FCF Margin | n/a |
Dividends & Yields
FRA:TD5A does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.23% |
| Shareholder Yield | -2.23% |
| Earnings Yield | -14.49% |
| FCF Yield | -1.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 10, 2017. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
FRA:TD5A has an Altman Z-Score of 0.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.61 |
| Piotroski F-Score | 3 |